Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HOXB9 |
| Upstream (Parents) |
|---|
| (<<) ATF5 → HOXB9 |
| (<<) HOXA10 → HOXB9 |
| (<<) AR → HOXB9 |
| (<<) NFE2L3 → HOXB9 |
| (<<) CEBPD → HOXB9 |
| (<<) MNX1 → HOXB9 |
| (<<) SOX9 → HOXB9 |
| (<<) CEBPA → HOXB9 |
| (<<) GTF2IRD1 → HOXB9 |
| (<<) HOXB5 → HOXB9 |
| Downstream (Children) |
|---|
| HOXB9 → HOXA9 (>>) |
| HOXB9 → ASCL2 (>>) |
| HOXB9 → SATB2 (>>) |
| HOXB9 → CDX2 (>>) |
| HOXB9 → SOX4 (>>) |
| HOXB9 → ETV4 (>>) |
| HOXB9 → HOXB8 (>>) |
| HOXB9 → HOXA11 (>>) |
| HOXB9 → GRHL2 (>>) |
| HOXB9 → TSHZ2 (>>) |
| HOXB9 → HOXB7 (>>) |
| HOXB9 → TCF3 (>>) |
| HOXB9 → HOXB6 (>>) |
| HOXB9 → T (>>) |
| HOXB9 → NR4A1 (>>) |
| HOXB9 → TFCP2L1 (>>) |
| HOXB9 → NKX2-5 (>>) |
| HOXB9 → PLAG1 (>>) |
| HOXB9 → TSC22D4 (>>) |
| HOXB9 → HOXB3 (>>) |
| HOXB9 → ELF3 (>>) |
| HOXB9 → ELF1 (>>) |
